Cetc Potevio Science&Technology Co.,Ltd. (SHE:002544)
China · Delayed Price · Currency is CNY 31.43
-0.45 (-1.41%)
Jan 30, 2026, 3:04 PM CST
SHE:002544 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 4,667 | 4,934 | 5,428 | 7,054 | 6,472 | 6,219 |
Other Revenue | 38.35 | 38.35 | 35.54 | 21.5 | 80.43 | 75.96 |
| 4,705 | 4,973 | 5,463 | 7,076 | 6,553 | 6,295 | |
Revenue Growth (YoY) | -5.83% | -8.98% | -22.79% | 7.98% | 4.09% | 1.11% |
Cost of Revenue | 3,951 | 4,124 | 4,536 | 5,746 | 5,336 | 5,185 |
Gross Profit | 754.42 | 848.28 | 927.26 | 1,329 | 1,217 | 1,111 |
Selling, General & Admin | 391.39 | 417.3 | 475.73 | 531.62 | 511.03 | 482.82 |
Research & Development | 204.7 | 251.61 | 274.28 | 322.05 | 382.5 | 350.41 |
Other Operating Expenses | 12.2 | -1.37 | 21.76 | 33.73 | 20.57 | 24.09 |
Operating Expenses | 729.93 | 835.53 | 933 | 1,049 | 1,026 | 944.2 |
Operating Income | 24.49 | 12.75 | -5.75 | 280.54 | 190.29 | 166.71 |
Interest Expense | -19.9 | -25.16 | -39.58 | -47.01 | -58.05 | -71.16 |
Interest & Investment Income | 20.93 | 31.57 | 29.23 | 27.66 | 37.53 | 5.76 |
Earnings From Equity Investments | - | - | - | - | - | -2.62 |
Currency Exchange Gain (Loss) | -1.54 | -1.54 | 0.67 | -2.12 | -2.64 | -3.11 |
Other Non Operating Income (Expenses) | -23.78 | -24.19 | 4.52 | -25.91 | -3.07 | -4.05 |
EBT Excluding Unusual Items | 0.19 | -6.58 | -10.91 | 233.16 | 164.06 | 91.53 |
Gain (Loss) on Sale of Investments | - | - | -0.12 | -5.89 | -2.33 | - |
Gain (Loss) on Sale of Assets | 0.17 | 0.08 | 0.04 | -0 | 0.06 | 0.24 |
Asset Writedown | -10.73 | -0.75 | -0.35 | -0.34 | -15.38 | -0.38 |
Other Unusual Items | 20.89 | 15.27 | 25.38 | 21.09 | 25.61 | 48.16 |
Pretax Income | 10.51 | 8.01 | 14.04 | 248.02 | 172.02 | 139.56 |
Income Tax Expense | 7.22 | 5.54 | -5.08 | 22.78 | 14.32 | 32.87 |
Earnings From Continuing Operations | 3.29 | 2.48 | 19.12 | 225.24 | 157.7 | 106.68 |
Minority Interest in Earnings | 7.21 | 8.71 | 16.47 | -11.85 | -16.13 | -10.4 |
Net Income | 10.5 | 11.19 | 35.59 | 213.39 | 141.57 | 96.28 |
Net Income to Common | 10.5 | 11.19 | 35.59 | 213.39 | 141.57 | 96.28 |
Net Income Growth | - | -68.55% | -83.32% | 50.73% | 47.04% | 163.09% |
Shares Outstanding (Basic) | 559 | 560 | 712 | 688 | 674 | 566 |
Shares Outstanding (Diluted) | 559 | 560 | 712 | 688 | 674 | 566 |
Shares Change (YoY) | -21.31% | -21.39% | 3.41% | 2.11% | 19.03% | -7.14% |
EPS (Basic) | 0.02 | 0.02 | 0.05 | 0.31 | 0.21 | 0.17 |
EPS (Diluted) | 0.02 | 0.02 | 0.05 | 0.31 | 0.21 | 0.17 |
EPS Growth | - | -60.00% | -83.87% | 47.62% | 23.53% | 183.33% |
Free Cash Flow | 98.1 | -129.17 | 154.14 | 105.66 | 71.52 | 304.24 |
Free Cash Flow Per Share | 0.17 | -0.23 | 0.22 | 0.15 | 0.11 | 0.54 |
Dividend Per Share | 0.008 | 0.008 | 0.026 | 0.157 | 0.104 | 0.071 |
Dividend Growth | -68.20% | -68.20% | -83.32% | 50.48% | 46.48% | 115.15% |
Gross Margin | 16.04% | 17.06% | 16.97% | 18.79% | 18.57% | 17.65% |
Operating Margin | 0.52% | 0.26% | -0.10% | 3.96% | 2.90% | 2.65% |
Profit Margin | 0.22% | 0.22% | 0.65% | 3.02% | 2.16% | 1.53% |
Free Cash Flow Margin | 2.08% | -2.60% | 2.82% | 1.49% | 1.09% | 4.83% |
EBITDA | 95.51 | 92.08 | 84.67 | 391.85 | 297.73 | 269.81 |
EBITDA Margin | 2.03% | 1.85% | 1.55% | 5.54% | 4.54% | 4.29% |
D&A For EBITDA | 71.01 | 79.33 | 90.42 | 111.3 | 107.44 | 103.1 |
EBIT | 24.49 | 12.75 | -5.75 | 280.54 | 190.29 | 166.71 |
EBIT Margin | 0.52% | 0.26% | -0.10% | 3.96% | 2.90% | 2.65% |
Effective Tax Rate | 68.69% | 69.08% | - | 9.19% | 8.32% | 23.56% |
Revenue as Reported | 4,705 | 4,973 | 5,463 | 7,076 | 6,553 | 6,295 |
Advertising Expenses | - | 1.16 | 1 | 0.35 | 1.62 | 0.94 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.